Experts say that a new FDA-approved screening tool for ADHD might lead to more accurate diagnoses of children ages 6 to 17 and help reduce overmedication — if used as intended as just one measure ...

A new technology can now be utilized on patients called the Quotient® ADHD Test. t is FDA-cleared for the objective measurement of hyperactivity, impulsivity and inattention, as an aid in the ...

GRAND RAPIDS, MICHIGAN / ACCESSWIRE / January 15, 2025 / Mentavi Health, a leader in evidence-based mental health solutions, today announced the results of its pioneering real-world validation study ...

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent disorder in adult psychiatry, particularly in out-patient settings. There are no objective, laboratory ...

Mentavi, a national leader in online mental health testing, will attend the 10th World Congress on ADHD and present a first-ever study comparing the accuracy and validity of an online asynchronous ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects an individual’s ability to manage their thoughts, actions and emotions ...

"From the initial East Midlands pilot programme across 3 local NHS trusts, within a couple of years via the 15 Health Innovation Networks, we are close to 100 per cent implementation across the NHS in ...

A new study published in the journal European Psychiatry indicates that adult women with attention-deficit/hyperactivity ...

The number of people with attention deficit hyperactivity disorder (ADHD) "probably isn't increasing that much", researchers have suggested, despite a "marked uptick" in people seeking assessment for ...